Epsilon Consulting worked with a nascent start-up biotechnology company to establish a coherent business plan and therapeutic antibody discovery strategy during fund raising. The company was successful in raising seed capital to support development of its first product.
Review of licensing opportunities as independent 3rd party on behalf of blinded clients prior to full engagement.